Table 1.
Author year | Country | Patients cohort | Number of participants | Mean age (years) | Male (%) | EMB sampling | Scanner brand | CMR variables analyzed |
---|---|---|---|---|---|---|---|---|
Mahrholdt 2006 | Germany | Suspected MC | 128 | 41.2 | 74.5 | LGE region or BV | Siemens 1.5T | LGE |
Yilmaz 2008 | Germany | Suspected MC | 69 | 58.4 | 32.9 | RV, LV or BV | Siemens 1.5T | LGE |
Gutberlet 2008 | Germany | Suspected CMC | 83 | 44.8 | 33.7 | IVS | GE 1.5T | gRE, ER, LGE, LLC |
Sramko 2013 | Czech | Suspected CMC | 42 | 43.9 | 71.4 | RV | Siemens 1.5T | gRE, ER, LGE, LLC |
Lurz 2014-AMC | Germany | Suspected AMC | 70 | 44.0 | 87.0 | LV | Philips 1.5T | gRE, ER, LGE, LLC |
Lurz 2014-CMC | Germany | Suspected CMC | 62 | 52.0 | 69.4 | LV | Philips 1.5T | gRE, ER, LGE, LLC |
Bohnen 2015 | Germany | Suspected MC | 31 | 51.0 | 77.0 | RV or LV | Philips 1.5T | LGE, LLC |
Lurz 2016-AMC | Germany | Suspected AMC | 61 | 40.0 | 83.0 | BV | Philips 1.5T | LGE, LLC |
Lurz 2016-CMC | Germany | Suspected CMC | 68 | 46.0 | 81.0 | BV | Philips 1.5T | LGE, LLC |
AMC – acute myocarditis; CMC – chronic myocarditis; MC – myocarditis; EMB – endomyocardial biopsy; CMR – cardiac magnetic resonance; ER – edema ratio; gRE – global relative enhancement; LGE – late gadolinium enhancement.